ConforMIS, Inc.

Company Details:

Company Symbol: CFMS
Sector: Healthcare & Medical Devices
Company Rating:

Related Research

  • 02/16/17 Update CFMS ($8.61, Buy; $7.50 PT): Revenue In-line with Consensus, but 2017 Guidance Disappoints – Lowering Estimates, Maintain Buy, and Reducing Price Target to $7.50.
  • 02/16/17 Morning Note B. Riley AM Note: ADI, AMAT, CFMS, CYTX, GDDY, GRPN, MAMS, MCHP, SONS, TIVO
  • 02/15/17 Update Industry Update: Medical Technology Fourth Quarter 2016 Earnings Preview for week of Feb. 13 (CFMS, MZOR, VIVE)
  • 02/15/17 Morning Note B. Riley AM Note: ADI, AVP, FLWS, IMAX, NCMI, OOMA, OSIS, PG, RCKY, SQNS, VFC, WWW, XCRA; MedTech (CFMS, MZOR, VIVE)
  • 01/06/17 Update Industry Update - MedTech: What Medical Technology Investors Should Know as the Healthcare Sector Descends on San Francisco on January 9-12, 2017
  • 11/04/16 Update CFMS ($8.61, Buy; $13.00 PT): Top-and Bottom-line Beat. “ConforMIS (Core Business) is Back!” – Tweaking Estimates, Maintain Buy and Price Target of $13.00.
  • 11/04/16 Morning Note B. Riley AM Note: ABTL, AOSL, CARB, CFMS, CTSO, CVU, DCO, DHX, FARM, FN, GUID, IMMR, KE, KW, LGF, MAT, NPTN, PBH, REIS, RNWK, ROG, SENS, STMP, SWKS, TIVO, TREC, TRUE, UEIC, VPG, WEB, WYY; B. Riley & Co. Focus List Update
  • 09/16/16 Initiation of Coverage CFMS ($8.61, Buy; $13.00 PT): Market Disruptor Trading at a Discount; Initiating at Buy with a $13.00 PT
  • 09/16/16 Morning Note B. Riley AM Note: AMAT, CFMS (initiating), EKSO (initiating), FTD (downgrade), NVRO (initiating), NVTR (initiating), OXM, P, PFSW, RELY, SQNS, TLYS; Footwear (CROX, DECK, RCKY, VFC, WEYS, WWW)